Macolić Sarinić V - Search Results

1

Regulating medicines in Croatia: five-year experience of Agency for Medicinal Products and Medical Devices.

Tomić S, Filipović Sucić A, Plazonić A, Truban Zulj R, Macolić Sarinić V, Cudina B, Ilić Martinac A. Tomić S, et al. Among authors: macolic sarinic v. Croat Med J. 2010 Apr;51(2):104-12. doi: 10.3325/cmj.2010.51.104. Croat Med J. 2010. PMID: 20401952 Free PMC article.

2

Adverse drug reactions caused by drug-drug interactions reported to Croatian Agency for Medicinal Products and Medical Devices: a retrospective observational study.

Mirosevic Skvrce N, Macolic Sarinic V, Mucalo I, Krnic D, Bozina N, Tomic S. Mirosevic Skvrce N, et al. Among authors: macolic sarinic v. Croat Med J. 2011 Oct 15;52(5):604-14. doi: 10.3325/cmj.2011.52.604. Croat Med J. 2011. PMID: 21990078 Free PMC article.

3

A retrospective review of paediatric adverse drug reactions reported in Lombardy and Croatia from 2005 to 2013.

Carnovale C, Gentili M, Matacena M, Dimov Di Giusti M, Krnic D, Dolinic B, Kolaric D, Margan Koletic Z, Macolic Sarinic V, Culjak M, Fortino I, Merlino L, Clementi E, Radice S. Carnovale C, et al. Among authors: macolic sarinic v. Expert Opin Drug Saf. 2016 Dec;15(sup2):35-43. doi: 10.1080/14740338.2016.1253678. Expert Opin Drug Saf. 2016. PMID: 27875921

4

Acquired coagulopathy due to anticoagulant rodenticide poisoning.

Huić M, Francetić I, Bakran I, Macolić-Sarinić V, Bilusić M. Huić M, et al. Among authors: macolic sarinic v. Croat Med J. 2002 Oct;43(5):615-7. Croat Med J. 2002. PMID: 12402407 Free article.

5

CYP2C9 and ABCG2 polymorphisms as risk factors for developing adverse drug reactions in renal transplant patients taking fluvastatin: a case-control study.

Miroševic Skvrce N, Božina N, Zibar L, Barišic I, Pejnovic L, Macolic Šarinic V. Miroševic Skvrce N, et al. Among authors: macolic sarinic v. Pharmacogenomics. 2013 Sep;14(12):1419-31. doi: 10.2217/pgs.13.135. Pharmacogenomics. 2013. PMID: 24024895

6

Clinical Application of Genotype-guided Dosing of Warfarin in Patients with Acute Stroke.

Šupe S, Poljaković Z, Božina T, Ljevak J, Macolić Šarinić V, Božina N. Šupe S, et al. Among authors: macolic sarinic v. Arch Med Res. 2015 May;46(4):265-73. doi: 10.1016/j.arcmed.2015.05.001. Epub 2015 May 16. Arch Med Res. 2015. PMID: 25989350 Free article.

7

Vaccine regulations in Croatia.

Kaić B, Gjenero-Margan I, Brzović M, Lakoseljac D, Aleraj B, Nemeth-Blazić T, Kolarić B, Macolić-Sarinić V, Simunović A, Pavlić J. Kaić B, et al. Among authors: macolic sarinic v. Coll Antropol. 2007 Apr;31 Suppl 2:117-20. Coll Antropol. 2007. PMID: 17598513

8

How safe are bioequivalence studies in healthy volunteers?

Huic M, Vrhovac B, Macolic-Sarinic V, Francetic I, Bakran I, Giljanovic S. Huic M, et al. Among authors: macolic sarinic v. Therapie. 1996 Jul-Aug;51(4):410-3. Therapie. 1996. PMID: 8953818

9

ABCG2 gene polymorphisms as risk factors for atorvastatin adverse reactions: a case-control study.

Mirošević Skvrce N, Macolić Šarinić V, Šimić I, Ganoci L, Muačević Katanec D, Božina N. Mirošević Skvrce N, et al. Among authors: macolic sarinic v. Pharmacogenomics. 2015 Jul;16(8):803-15. doi: 10.2217/pgs.15.47. Epub 2015 Jun 18. Pharmacogenomics. 2015. PMID: 26086347

10

Rosuvastatin-Induced Rhabdomyolysis - Possible Role of Ticagrelor and Patients' Pharmacogenetic Profile.

Vrkić Kirhmajer M, Macolić Šarinić V, Šimičević L, Ladić I, Putarek K, Banfić L, Božina N. Vrkić Kirhmajer M, et al. Among authors: macolic sarinic v. Basic Clin Pharmacol Toxicol. 2018 Oct;123(4):509-518. doi: 10.1111/bcpt.13035. Epub 2018 Jun 29. Basic Clin Pharmacol Toxicol. 2018. PMID: 29734517 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

15 results

Search Page